A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma
Clinical trial NCT05653427 · TERMINATED
Trial details
- NCT number
- NCT05653427
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-08
- Primary completion
- 2023-10-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.